使TCR-CAR

Mohammad Shahbazy1, Isabelle Rose Leo2, Pouya Faridi3

  • 1Department of Immunobiology, Yale School of Medicine, New Haven, CT, USA.

PubMed
概括

研究人员设计了T细胞受体 (TCR) 和仿真抗原受体 (CAR) 来创建一个制动系统. 该系统增强和抑制CAR激活,可能限制健康组织中CAR-T疗法的毒性.

相关概念视频

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K